Researchers have found in a phase 3 trial that phentolamine ophthalmic solution 0.75% led to significant improvements in ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

The Food and Drug Administration (FDA) has approved Tryptyr ® (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.. The active ingredient in ...

Then, on Tuesday, The U.S. Food and Drug Administration (FDA) published a report detailing the recall of bromfenac ophthalmic solution eye drops nationwide. The bottles appear to be available by ...

The ophthalmic solution will be available in single-dose vials with a recommended dosage of one drop in each eye twice a day. Approval of Tryptyr was based on the results of two phase 3 clinical ...

“Our collaboration with Kinetiq and Pier Two marks a strategic step in realizing a shared vision for secure, composable, and deeply integrated liquid staking on Hyperliquid,” said Hyunsu Jung, Chief ...

LONDON, GREATER LONDON, UNITED KINGDOM, June 13, 2025 /EINPresswire.com/ -- There has been a significant expansion in the cyclosporine drugs market size in recent years. The detailed analysis suggests ...

The Food and Drug Administration (FDA) has approved Tryptyr ® (acoltremon ophthalmic solution) 0.003% for the treatment of the signs and symptoms of dry eye disease.. The active ingredient in Tryptyr ...

A few weeks ago, over 1.8 million eye drops apparently used to relieve dry eye symptoms were recalled due to manufacturing deviations. Soon after, more than 60,000 eye drops were recalled. Then, on ...

Today, the FDA approved Tryptyr (acoltremon ophthalmic solution 0.003%), a new eye drop developed by Alcon, for the treatment of both signs and symptoms of Dry Eye Disease (DED).. Formerly known as AR ...